Osteoboost in the news

PT Products Online announces Osteoboost’s pre-order launch; FDA-cleared wearable uses vibration therapy to reduce spine bone loss by 85% in women.

Longevity Live features Osteoboost, an FDA-cleared wearable delivering vibration therapy to reduce spinal bone loss by 85% in postmenopausal women.

Elite Wellness Oracle explores how Osteoboost’s innovative vibration therapy is changing the game for women seeking non-drug solutions to low bone density.

Healthcare Brew highlights Osteoboost’s FDA-cleared vibrating belt as a 2024 breakthrough, reducing spine bone loss in postmenopausal women.

Movement Logic Podcast reviews Osteoboost, an FDA-cleared wearable using vibration therapy to improve bone density in postmenopausal women.

Femtech Insider announces Osteoboost’s FDA-cleared wearable, now available for pre-order, offering non-drug vibration therapy to reduce spinal bone loss.

HIT Consultant announces Osteoboost’s FDA clearance and pre-order launch; wearable delivers vibration therapy to reduce spine bone loss in women.

Ubergizmo features Osteoboost, an FDA-cleared wearable using vibration therapy to reduce spine bone loss by 85% in postmenopausal women.

BHOF spotlights Osteoboost’s FDA-cleared wearable, offering non-drug vibration therapy to reduce bone loss in postmenopausal women with osteopenia.

Osteoboost's Chief Medical Officer Dr. Pamela Peeke, MD and Chief Product Officer Priya Patel join BHOF to discuss strategies to improve bone health.

Boomer Tech Talk explores Osteoboost’s FDA-cleared wearable for osteopenia, featuring insights from CSO Mike Jaasma, PhD and CPO Priya Patel.

NIA features Osteoboost, an FDA-cleared wearable delivering targeted vibration therapy to reduce bone loss in postmenopausal women with osteopenia.